More than 70% of individuals with diabetes develop some form of heart disease. Nonischemic diabetic heart disease (NiDHD) is a chronic complication characterized by ventricular dilation and hypertrophy, diastolic dysfunction, and decreased or preserved systolic function, and eventually may result in heart failure.
Ten targeted cancer drugs currently being tested in clinical trials involving 1,000 patients do not reach the targets at which they are aimed, according to research published this week.
